You can buy or sell OCUL and other stocks, options, ETFs, and crypto commission-free!
Ocular Therapeutix, Inc. Common Stock, also called Ocular Therapeutix, is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Read More Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
52 Week High
52 Week Low
— per share
Expected Aug 7, Pre-Market